Ginsenosides in hepatocellular carcinoma: preclinical evidence, mechanisms, and clinical implications.
Journal: Frontiers in Pharmacology
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Yu C, Zhu X, Liu S, et al. (2026). "Ginsenosides in hepatocellular carcinoma: preclinical evidence, mechanisms, and clinical implications.". Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1973780